BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8873729)

  • 1. Inhibition of lipid peroxidation with the lazaroid U74500A attenuates ischemia-reperfusion injury in a canine orthotopic heart transplantation model.
    Tanoue Y; Morita S; Ochiai Y; Hisahara M; Masuda M; Kawachi Y; Tominaga R; Yasui H
    J Thorac Cardiovasc Surg; 1996 Oct; 112(4):1017-26. PubMed ID: 8873729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful twenty-four-hour canine lung preservation with lazaroid U74500A.
    Tanoue Y; Morita S; Ochiai Y; Zhang QW; Hisahara M; Miyamoto K; Nishida T; Kawachi Y; Tominaga R; Yasui H
    J Heart Lung Transplant; 1996 Jan; 15(1 Pt 1):43-50. PubMed ID: 8820082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitroglycerin as a nitric oxide donor accelerates lipid peroxidation but preserves ventricular function in a canine model of orthotopic heart transplantation.
    Tanoue Y; Morita S; Ochiai Y; Haraguchi N; Tominaga R; Kawachi Y; Yasui H
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):547-56. PubMed ID: 10469974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective effects of Lazaroid U-74389G on ischemia-reperfusion injury in canine hearts.
    Takahashi T; Takeyoshi I; Hasegawa Y; Koyano T; Yamagishi T; Oshima K; Matsumoto K; Morishita Y
    J Heart Lung Transplant; 1999 Apr; 18(4):285-91. PubMed ID: 10226891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of the University of Wisconsin solution over simple crystalloid for extended heart preservation. A study of left ventricular pressure-volume relationship.
    Ko W; Zelano JA; Lazzaro R; Lazenby WD; Hamilton T; Isom OW; Krieger KH
    J Thorac Cardiovasc Surg; 1992 May; 103(5):980-92. PubMed ID: 1569779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lazaroid (U74500A), a novel inhibitor of lipid peroxidation, on 24-hour heart preservation. A study based on a working model using cross-circulated blood-perfused rabbit hearts.
    Nishida T; Morita S; Miyamoto K; Masuda M; Tominaga R; Kawachi Y; Yasui H
    Transplantation; 1996 Jan; 61(2):194-9. PubMed ID: 8600622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lazaroid U74500A as an additive to University of Wisconsin solution for pulmonary grafts in the rat transplant model.
    Aeba R; Killinger WA; Keenan RJ; Yousem SA; Hamamoto I; Hardesty RL; Griffith BP
    J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1333-9. PubMed ID: 1434715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved donor myocardial recovery with a new lazaroid lipid antiperoxidant in the isolated canine heart.
    Hendry PJ; Anstadt MP; Plunkett MD; Amato MT; Menius JA; Lowe JE
    J Heart Lung Transplant; 1992; 11(4 Pt 1):636-45. PubMed ID: 1498126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lazaroid (U74500A) prevents vascular and myocardial dysfunction after 24-hour heart preservation. A study based on cross-circulated blood-perfused rabbit hearts.
    Nishida T; Morita S; Miyamoto K; Masuda M; Tominaga R; Kawachi Y; Yasui H
    Circulation; 1996 Nov; 94(9 Suppl):II326-31. PubMed ID: 8901769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lazaroid U74006F, a 21-aminosteroid inhibitor of lipid peroxidation, attenuates myocardial injury from ischemia and reperfusion.
    Carrea FP; Lesnefsky EJ; Kaiser DG; Horwitz LD
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):230-5. PubMed ID: 1381014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK409 ameliorates ischemia-reperfusion injury in heart transplantation following 12-hour cold preservation.
    Mohara J; Oshima K; Tsutsumi H; Takeyoshi I; Matsumoto K; Morishita Y
    J Heart Lung Transplant; 2000 Jul; 19(7):694-700. PubMed ID: 10930819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lazaroid U74500A is superior to U74006F in preserving rabbit heart for 24 hours.
    Nishida T; Morita S; Masuda M; Tominaga R; Kawachi Y; Yasui H
    Ann Thorac Surg; 1998 Nov; 66(5):1647-52. PubMed ID: 9875765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of rat heart from ischaemia-reperfusion injury by the 21-aminosteroid U-74389G.
    Perna AM; Liguori P; Bonacchi M; Laino GM; Nediani C; Fiorillo C; Lunghi B; Zecchi-Orlandini S; Formigli L; Ibba-Manneschi L; Nassi P
    Pharmacol Res; 1996; 34(1-2):25-31. PubMed ID: 8981552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection by coenzyme Q10 of canine myocardial reperfusion injury after preservation.
    Matsushima T; Sueda T; Matsuura Y; Kawasaki T
    J Thorac Cardiovasc Surg; 1992 May; 103(5):945-51. PubMed ID: 1569776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart preservation: analysis of cardioprotective infusate characteristics. Membrane stabilization, calcium antagonism, and protease inhibition on myocardial viability: a biochemical, ultrastructural, functional study.
    Sultan I; Sunamori M; Suzuki A
    J Heart Lung Transplant; 1992; 11(4 Pt 1):607-18. PubMed ID: 1379828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl pyruvate preserves cardiac function and attenuates oxidative injury after prolonged myocardial ischemia.
    Woo YJ; Taylor MD; Cohen JE; Jayasankar V; Bish LT; Burdick J; Pirolli TJ; Berry MF; Hsu V; Grand T
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1262-9. PubMed ID: 15115981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase-2 improves cardiac function following long-term preservation.
    Oshima K; Takeyoshi I; Tsutsumi H; Mohara J; Ohki S; Koike N; Nameki T; Matsumoto K; Morishita Y
    J Surg Res; 2006 Oct; 135(2):380-4. PubMed ID: 16713604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mechanism for cyclosporine: inhibition of myocardial ischemia and reperfusion injury in a heterotopic rabbit heart transplant model.
    Gatewood LB; Larson DF; Bowers MC; Bond S; Cardy A; Sethi GK; Copeland JG
    J Heart Lung Transplant; 1996 Sep; 15(9):936-47. PubMed ID: 8889990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compositional analysis of a modified University of Wisconsin solution for extended myocardial preservation. A study of the left ventricular pressure-volume relation.
    Ko W; Zelano JA; Lazenby WD; Isom OW; Krieger KH
    Circulation; 1992 Nov; 86(5 Suppl):II326-32. PubMed ID: 1424021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
    Abd-Elfattah AS; Ding M; Wechsler AS
    J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.